These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 19853423)

  • 21. Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content.
    Budhian A; Siegel SJ; Winey KI
    Int J Pharm; 2007 May; 336(2):367-75. PubMed ID: 17207944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Water-free microencapsulation of proteins within PLGA microparticles by spray drying using PEG-assisted protein solubilization technique in organic solvent.
    Mok H; Park TG
    Eur J Pharm Biopharm; 2008 Sep; 70(1):137-44. PubMed ID: 18515053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of post-emulsification drying processes on the microencapsulation of human serum albumin.
    Lane ME; Brennan FS; Corrigan OI
    Int J Pharm; 2006 Jan; 307(1):16-22. PubMed ID: 16274944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stabilization and encapsulation of a staphylokinase variant (K35R) into poly(lactic-co-glycolic acid) microspheres.
    He JT; Su HB; Li GP; Tao XM; Mo W; Song HY
    Int J Pharm; 2006 Feb; 309(1-2):101-8. PubMed ID: 16413979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation of rifampicin-loaded PLGA microspheres for lung delivery as aerosol by premix membrane homogenization.
    Doan TV; Olivier JC
    Int J Pharm; 2009 Dec; 382(1-2):61-6. PubMed ID: 19682562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Production of microspheres with surface amino groups from blends of Poly(Lactide-co-glycolide) and Poly(epsilon-CBZ-L-lysine) and use for encapsulation.
    Zheng J; Hornsby PJ
    Biotechnol Prog; 1999; 15(4):763-7. PubMed ID: 10441368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and optimization of NSAID loaded nanoparticles.
    Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK
    Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles.
    Kumar PS; Ramakrishna S; Saini TR; Diwan PV
    Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Particle size control of poly(dl-lactide-co-glycolide) nanospheres for sterile applications.
    Tsukada Y; Hara K; Bando Y; Huang CC; Kousaka Y; Kawashima Y; Morishita R; Tsujimoto H
    Int J Pharm; 2009 Mar; 370(1-2):196-201. PubMed ID: 19100320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of ciprofloxacin-loaded Eudragit RS100 or RL100/PLGA nanoparticles.
    Dillen K; Vandervoort J; Van den Mooter G; Ludwig A
    Int J Pharm; 2006 May; 314(1):72-82. PubMed ID: 16600538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation of large porous biodegradable microspheres by using a simple double-emulsion method for capreomycin sulfate pulmonary delivery.
    Giovagnoli S; Blasi P; Schoubben A; Rossi C; Ricci M
    Int J Pharm; 2007 Mar; 333(1-2):103-11. PubMed ID: 17079101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Poly(lactic-co-glycolic acid) as a particulate emulsifier.
    Whitby CP; Lim LH; Eskandar NG; Simovic S; Prestidge CA
    J Colloid Interface Sci; 2012 Jun; 375(1):142-7. PubMed ID: 22440727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kinetics of solvent extraction/evaporation process for PLGA microparticle fabrication.
    Katou H; Wandrey AJ; Gander B
    Int J Pharm; 2008 Nov; 364(1):45-53. PubMed ID: 18782610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PLGA-based drug delivery systems: importance of the type of drug and device geometry.
    Klose D; Siepmann F; Elkharraz K; Siepmann J
    Int J Pharm; 2008 Apr; 354(1-2):95-103. PubMed ID: 18055140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymeric nanoparticles encapsulating betamethasone phosphate with different release profiles and stealthiness.
    Ishihara T; Kubota T; Choi T; Takahashi M; Ayano E; Kanazawa H; Higaki M
    Int J Pharm; 2009 Jun; 375(1-2):148-54. PubMed ID: 19481700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanoscale surface characterization and miscibility study of a spray-dried injectable polymeric matrix consisting of poly(lactic-co-glycolic acid) and polyvinylpyrrolidone.
    Meeus J; Chen X; Scurr DJ; Ciarnelli V; Amssoms K; Roberts CJ; Davies MC; van Den Mooter G
    J Pharm Sci; 2012 Sep; 101(9):3473-85. PubMed ID: 22447580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hydrolytic degradation characteristics of irradiated multi-layered PLGA films.
    Joachim Loo SC; Jason Tan WL; Khoa SM; Chia NK; Venkatraman S; Boey F
    Int J Pharm; 2008 Aug; 360(1-2):228-30. PubMed ID: 18514448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A study of drug release from homogeneous PLGA microstructures.
    Acharya G; Shin CS; Vedantham K; McDermott M; Rish T; Hansen K; Fu Y; Park K
    J Control Release; 2010 Sep; 146(2):201-6. PubMed ID: 20381555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Poly (lactic-co-glycolic acid) particles prepared by microfluidics and conventional methods. Modulated particle size and rheology.
    Perez A; Hernández R; Velasco D; Voicu D; Mijangos C
    J Colloid Interface Sci; 2015 Mar; 441():90-7. PubMed ID: 25490568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Controlling the stability and size of double-emulsion-templated poly(lactic-co-glycolic) acid microcapsules.
    Tu F; Lee D
    Langmuir; 2012 Jul; 28(26):9944-52. PubMed ID: 22667691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.